EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Human TSC2 mutant cells exhibit aberrations in early neurodevelopment accompanied by changes in the DNA Methylome

Mary-Bronwen L Chalkley, Lindsey N Guerin, Tenhir Iyer, Samantha Mallahan, Sydney Nelson, Mustafa Sahin iD, Emily Hodges, Kevin C Ess, Rebecca A Ihrie iD

Human Molecular Genetics · 2025

DOI: 10.1093/hmg/ddae199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Mary-Bronwen L Chalkley und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell & Developmental Biology, Vanderbilt University School of Medicine, 1161 21st Ave S, Nashville, Tennessee, 37232, United States of …. Hauptthemen laut MEDLINE: Tuberous Sclerosis Complex 2 Protein, Tuberous Sclerosis, DNA Methylation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NICHD NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberous Sclerosis Complex (TSC) is a debilitating developmental disorder characterized by a variety of clinical manifestations. While benign tumors in the heart, lungs, kidney, and brain are all hallmarks of the disease, the most severe symptoms of TSC are often neurological, including seizures, autism, psychiatric disorders, and intellectual disabilities. TSC is caused by loss of function mutations in the TSC1 or TSC2 genes and consequent dysregulation of signaling via mechanistic Target of Rapamycin Complex 1 (mTORC1). While TSC neurological phenotypes are well-documented, it is not yet known how early in neural development TSC1/2-mutant cells diverge from the typical developmental trajectory. Another outstanding question is the contribution of homozygous-mutant cells to disease phenotypes and whether phenotypes are also present in the heterozygous-mutant populations that comprise the vast majority of cells in patients. Using TSC patient-derived isogenic induced pluripotent stem cells (iPSCs) with defined genetic changes, we observed aberrant early neurodevelopment in vitro, including misexpression of key proteins associated with lineage commitment and premature electrical activity. These alterations in differentiation were coincident with hundreds of differentially methylated DNA regions, including loci associated with key genes in neurodevelopment. Collectively, these data suggest that mutation or loss of TSC2 affects gene regulation and expression at earlier timepoints than previously appreciated, with implications for whether and how prenatal treatment should be pursued.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberous Sclerosis Complex 2 ProteinTuberous SclerosisDNA MethylationHumansInduced Pluripotent Stem CellsMutationTuberous Sclerosis Complex 1 ProteinMechanistic Target of Rapamycin Complex 1Cell DifferentiationEpigenome

Stichwörter der Autor:innen

DNA methylationiPS cellsneurodevelopmenttuberous sclerosis

Substanzen

Tuberous Sclerosis Complex 2 ProteinTSC2 protein, humanTuberous Sclerosis Complex 1 ProteinMechanistic Target of Rapamycin Complex 1TSC1 protein, human

Autor:innen und Institutionen

  • Department of Cell & Developmental Biology, Vanderbilt University School of Medicine, 1161 21st Ave S, Nashville, Tennessee, 37232, United States of America.
  • Department of Biochemistry, Vanderbilt University School of Medicine, 1161 21st Ave S, Nashville, Tennessee, 37232, United States of America.
  • Department of Pediatrics, Vanderbilt University Medical Center, 1211 Medical Center Dr, Nashville, Tennessee, 37232, United States of America.
  • Rosamund Stone Zander Translational Neuroscience Center, Department of Neurology, Harvard Medical School, 25 Shattuck Street, Boston, Massachusetts, 02115, United States of America.
  • Vanderbilt Genetics Institute, Vanderbilt University School of Medicine, 1161 21st Ave S, Nashville, TN, 37232, USA.
  • Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 2220 Pierce Ave, Nashville, TN, 37232, USA.

ORCID-Profile: Mustafa Sahin, Rebecca A Ihrie

Förderung

  • NIGMS NIH HHS
  • NICHD NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • Vanderbilt University Stanley Cohen
  • National Institutes of Health

Zitieren

APA

Chalkley, M. L., Guerin, L. N., Iyer, T., Mallahan, S., Nelson, S., Sahin, M., Hodges, E., Ess, K. C., & Ihrie, R. A. (2025). Human TSC2 mutant cells exhibit aberrations in early neurodevelopment accompanied by changes in the DNA Methylome. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae199

Vancouver

Chalkley ML, Guerin LN, Iyer T, Mallahan S, Nelson S, Sahin M, et al. Human TSC2 mutant cells exhibit aberrations in early neurodevelopment accompanied by changes in the DNA Methylome. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddae199

BibTeX
@article{Chalkley2025,
  author = {Chalkley, Mary-Bronwen L and Guerin, Lindsey N and Iyer, Tenhir and Mallahan, Samantha and Nelson, Sydney and Sahin, Mustafa and Hodges, Emily and Ess, Kevin C and Ihrie, Rebecca A},
  title = {Human TSC2 mutant cells exhibit aberrations in early neurodevelopment accompanied by changes in the DNA Methylome},
  journal = {Human Molecular Genetics},
  year = {2025},
  doi = {10.1093/hmg/ddae199}
}
Kostenlos starten →